Exercise for Atrial Fibrillation
(EASE-AF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a digital exercise program using a Fitbit can help individuals with atrial fibrillation (AF) feel better and experience fewer symptoms. AF causes the heart to beat irregularly, leading to palpitations or shortness of breath. Participants will use a Fitbit to monitor their physical activity, focusing on moderate to vigorous exercise. Those who experience intermittent AF symptoms and currently engage in 30 to 120 minutes of exercise weekly may be suitable for this trial. The goal is to develop a new, accessible exercise program for individuals with AF. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance exercise programs for AF patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise intervention using a FitBit wearable device is safe for patients with atrial fibrillation?
Research has shown that using a FitBit to track physical activity can help people with atrial fibrillation (AF) reach recommended exercise levels. This is linked to better heart health and a lower risk of AF. No reports indicate that the FitBit causes harm or is unsafe for people with AF. It counts steps and tracks activity, encouraging people to stay active. Studies have demonstrated that exercise is generally safe and beneficial for heart health. This method uses technology to help people with AF stay active without introducing new risks.12345
Why are researchers excited about this trial?
Researchers are excited about using a FitBit wearable device for atrial fibrillation (AF) because it offers a non-invasive and accessible way to manage the condition through physical activity. Unlike traditional treatments, such as medications or surgical interventions that focus on controlling heart rate or rhythm, this approach emphasizes lifestyle modification. The use of a FitBit allows for real-time monitoring and personalized exercise plans, empowering patients to take an active role in managing their health, which could lead to improved symptoms and quality of life.
What evidence suggests that this digital health-driven exercise intervention is effective for atrial fibrillation?
This trial will evaluate the use of a FitBit to track physical activity in patients with atrial fibrillation (AF). Studies have shown that a FitBit can help people with AF stay active, which is linked to better heart health and a lower risk of AF. Research indicates that individuals with AF tend to move less, but wearable devices can motivate them to reach exercise goals. This increase in physical activity is associated with fewer symptoms and a reduced impact of AF. Moreover, digital health tools like FitBits allow for better monitoring of heart health, leading to improved management of AF symptoms. Overall, using these devices to encourage exercise might be a promising way to help manage AF.12346
Who Is on the Research Team?
Janice Y Chyou, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for individuals who experience intermittent (paroxysmal) atrial fibrillation and have symptoms. It's designed to help those without easy access to exercise programs. Participants will be monitored using a FitBit device as part of the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Run-in Control
Participants undergo a 4-week run-in control period to establish baseline measurements
Physical Activity Intervention
Participants engage in a 24-week digital health-driven, patient-centered exercise intervention
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Physical Activity Intervention Using FitBit Wearable Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
American Heart Association
Collaborator